Roche (RHHBY) and Novartis (NVS) tout their U.S. investments as President Donald Trump imposes new 100% pharma tariffs. Read ...

Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast ...

Trump’s threat of a 100% tariff on imported branded or patented drugs sounds dramatic, yet, pharma stocks were mostly in the ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.1% in the afternoon session after the company halted a ...

President Trump plans to impose high import taxes on various goods, including pharmaceuticals, citing national security ...

Eli Lilly and Company (NYSE: LLY) is one of the 10 Best AI Stocks to Buy According to Goldman Sachs. On September 18, Wells ...

Even though Eli Lilly and Company (NYSE:LLY)’s shares have lost 6.9% year-to-date, Cramer continues to be a believer in the ...

Eli Lilly (NYSE: LLY) recently released top-line results from a head-to-head trial of its oral GLP-1 pill, orforglipron, compared to Novo Nordisk's (NYSE: NVO) oral version of Weg ...

The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable ...